nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—UGT1A8—tongue—pharynx cancer	0.0371	0.0916	CbGeAlD
Valproic Acid—UGT1A8—mouth—pharynx cancer	0.0249	0.0616	CbGeAlD
Valproic Acid—OGDH—mouth—pharynx cancer	0.0232	0.0573	CbGeAlD
Valproic Acid—ACADSB—Amino acid and derivative metabolism—CNDP2—pharynx cancer	0.0199	0.0334	CbGpPWpGaD
Valproic Acid—UGT1A8—Phase II conjugation—CNDP2—pharynx cancer	0.0192	0.0322	CbGpPWpGaD
Valproic Acid—UGT1A4—mouth—pharynx cancer	0.0189	0.0467	CbGeAlD
Valproic Acid—CYP2A6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0169	0.0284	CbGpPWpGaD
Valproic Acid—OGDH—Amino acid and derivative metabolism—CNDP2—pharynx cancer	0.0169	0.0284	CbGpPWpGaD
Valproic Acid—UGT2B15—Phase II conjugation—CNDP2—pharynx cancer	0.0167	0.0281	CbGpPWpGaD
Valproic Acid—HDAC2—tongue—pharynx cancer	0.0155	0.0384	CbGeAlD
Valproic Acid—CYP2A6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0148	0.0249	CbGpPWpGaD
Valproic Acid—UGT1A6—Phase II conjugation—CNDP2—pharynx cancer	0.014	0.0235	CbGpPWpGaD
Valproic Acid—ACADSB—parotid gland—pharynx cancer	0.0128	0.0317	CbGeAlD
Valproic Acid—ACADSB—saliva-secreting gland—pharynx cancer	0.0123	0.0303	CbGeAlD
Valproic Acid—OGDH—trachea—pharynx cancer	0.0119	0.0295	CbGeAlD
Valproic Acid—UGT1A8—Biological oxidations—CNDP2—pharynx cancer	0.0112	0.0188	CbGpPWpGaD
Valproic Acid—UGT1A4—Phase II conjugation—CNDP2—pharynx cancer	0.0108	0.0181	CbGpPWpGaD
Valproic Acid—ALDH5A1—brainstem—pharynx cancer	0.0106	0.0262	CbGeAlD
Valproic Acid—HDAC9—trachea—pharynx cancer	0.0105	0.026	CbGeAlD
Valproic Acid—HDAC2—mouth—pharynx cancer	0.0104	0.0258	CbGeAlD
Valproic Acid—OGDH—lymphoid tissue—pharynx cancer	0.0104	0.0257	CbGeAlD
Valproic Acid—UGT1A8—Biological oxidations—ADH7—pharynx cancer	0.0101	0.017	CbGpPWpGaD
Valproic Acid—UGT2B15—Biological oxidations—CNDP2—pharynx cancer	0.0098	0.0165	CbGpPWpGaD
Valproic Acid—ACADSB—trachea—pharynx cancer	0.00947	0.0234	CbGeAlD
Valproic Acid—OGDH—spinal cord—pharynx cancer	0.00941	0.0233	CbGeAlD
Valproic Acid—HDAC9—lymphoid tissue—pharynx cancer	0.00915	0.0226	CbGeAlD
Valproic Acid—ABAT—brainstem—pharynx cancer	0.00906	0.0224	CbGeAlD
Valproic Acid—UGT1A8—head—pharynx cancer	0.009	0.0222	CbGeAlD
Valproic Acid—UGT1A3—Phase II conjugation—CNDP2—pharynx cancer	0.00897	0.0151	CbGpPWpGaD
Valproic Acid—HDAC2—neck—pharynx cancer	0.00893	0.0221	CbGeAlD
Valproic Acid—UGT1A8—Biological oxidations—ADH1B—pharynx cancer	0.00889	0.0149	CbGpPWpGaD
Valproic Acid—UGT2B15—Biological oxidations—ADH7—pharynx cancer	0.00886	0.0149	CbGpPWpGaD
Valproic Acid—UGT1A6—NRF2 pathway—ADH7—pharynx cancer	0.00843	0.0142	CbGpPWpGaD
Valproic Acid—OGDH—head—pharynx cancer	0.00837	0.0207	CbGeAlD
Valproic Acid—UGT1A6—Biological oxidations—CNDP2—pharynx cancer	0.00818	0.0137	CbGpPWpGaD
Valproic Acid—CYP1A2—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.00803	0.0135	CbGpPWpGaD
Valproic Acid—CYP2C18—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00781	0.0131	CbGpPWpGaD
Valproic Acid—UGT2B15—Biological oxidations—ADH1B—pharynx cancer	0.00777	0.0131	CbGpPWpGaD
Valproic Acid—UGT2B7—Phase II conjugation—CNDP2—pharynx cancer	0.00763	0.0128	CbGpPWpGaD
Valproic Acid—ACADSB—spinal cord—pharynx cancer	0.00748	0.0185	CbGeAlD
Valproic Acid—UGT1A6—Biological oxidations—ADH7—pharynx cancer	0.0074	0.0124	CbGpPWpGaD
Valproic Acid—HDAC9—head—pharynx cancer	0.00738	0.0182	CbGeAlD
Valproic Acid—ALDH5A1—lymphoid tissue—pharynx cancer	0.00726	0.0179	CbGeAlD
Valproic Acid—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.00704	0.0118	CbGpPWpGaD
Valproic Acid—HDAC2—saliva-secreting gland—pharynx cancer	0.00696	0.0172	CbGeAlD
Valproic Acid—CYP2C18—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00685	0.0115	CbGpPWpGaD
Valproic Acid—HDAC2—brainstem—pharynx cancer	0.00682	0.0169	CbGeAlD
Valproic Acid—ALDH5A1—spinal cord—pharynx cancer	0.00658	0.0163	CbGeAlD
Valproic Acid—UGT1A4—NRF2 pathway—ADH7—pharynx cancer	0.00651	0.0109	CbGpPWpGaD
Valproic Acid—UGT1A6—Biological oxidations—ADH1B—pharynx cancer	0.00648	0.0109	CbGpPWpGaD
Valproic Acid—UGT1A4—Biological oxidations—CNDP2—pharynx cancer	0.00631	0.0106	CbGpPWpGaD
Valproic Acid—UGT1A9—Phase II conjugation—CNDP2—pharynx cancer	0.0062	0.0104	CbGpPWpGaD
Valproic Acid—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0062	0.0104	CbGpPWpGaD
Valproic Acid—HDAC2—epithelium—pharynx cancer	0.00608	0.015	CbGeAlD
Valproic Acid—OGDH—lymph node—pharynx cancer	0.00586	0.0145	CbGeAlD
Valproic Acid—ALDH5A1—head—pharynx cancer	0.00585	0.0145	CbGeAlD
Valproic Acid—UGT1A4—Biological oxidations—ADH7—pharynx cancer	0.00571	0.00959	CbGpPWpGaD
Valproic Acid—ABAT—spinal cord—pharynx cancer	0.00563	0.0139	CbGeAlD
Valproic Acid—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.00543	0.00913	CbGpPWpGaD
Valproic Acid—UGT1A3—NRF2 pathway—ADH7—pharynx cancer	0.00541	0.00909	CbGpPWpGaD
Valproic Acid—SLC16A1—epithelium—pharynx cancer	0.0054	0.0133	CbGeAlD
Valproic Acid—UGT1A3—Biological oxidations—CNDP2—pharynx cancer	0.00525	0.00882	CbGpPWpGaD
Valproic Acid—HDAC9—lymph node—pharynx cancer	0.00516	0.0128	CbGeAlD
Valproic Acid—PTGS1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00503	0.00845	CbGpPWpGaD
Valproic Acid—UGT1A4—Biological oxidations—ADH1B—pharynx cancer	0.00501	0.00841	CbGpPWpGaD
Valproic Acid—ABAT—head—pharynx cancer	0.00501	0.0124	CbGeAlD
Valproic Acid—CYP2A6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00476	0.00799	CbGpPWpGaD
Valproic Acid—UGT1A3—Biological oxidations—ADH7—pharynx cancer	0.00475	0.00797	CbGpPWpGaD
Valproic Acid—HDAC2—lymphoid tissue—pharynx cancer	0.00468	0.0116	CbGeAlD
Valproic Acid—ACADSB—lymph node—pharynx cancer	0.00465	0.0115	CbGeAlD
Valproic Acid—UGT2B7—NRF2 pathway—ADH7—pharynx cancer	0.0046	0.00773	CbGpPWpGaD
Valproic Acid—CYP2C18—Biological oxidations—CNDP2—pharynx cancer	0.00459	0.00771	CbGpPWpGaD
Valproic Acid—UGT2B7—Biological oxidations—CNDP2—pharynx cancer	0.00446	0.0075	CbGpPWpGaD
Valproic Acid—PTGS1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00441	0.00741	CbGpPWpGaD
Valproic Acid—HDAC9—Neural Crest Differentiation—CDH1—pharynx cancer	0.0042	0.00706	CbGpPWpGaD
Valproic Acid—CYP2A6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00417	0.00701	CbGpPWpGaD
Valproic Acid—UGT1A3—Biological oxidations—ADH1B—pharynx cancer	0.00416	0.00699	CbGpPWpGaD
Valproic Acid—CYP2C18—Biological oxidations—ADH7—pharynx cancer	0.00415	0.00697	CbGpPWpGaD
Valproic Acid—ALDH5A1—lymph node—pharynx cancer	0.0041	0.0101	CbGeAlD
Valproic Acid—UGT2B7—Biological oxidations—ADH7—pharynx cancer	0.00404	0.00678	CbGpPWpGaD
Valproic Acid—CYP2B6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00384	0.00645	CbGpPWpGaD
Valproic Acid—HDAC2—head—pharynx cancer	0.00377	0.00932	CbGeAlD
Valproic Acid—SLC16A1—spinal cord—pharynx cancer	0.00377	0.00932	CbGeAlD
Valproic Acid—CYP3A5—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00375	0.0063	CbGpPWpGaD
Valproic Acid—UGT1A9—NRF2 pathway—ADH7—pharynx cancer	0.00374	0.00628	CbGpPWpGaD
Valproic Acid—SLC22A5—parotid gland—pharynx cancer	0.00369	0.00912	CbGeAlD
Valproic Acid—ACADSB—Metabolism—CNDP2—pharynx cancer	0.00365	0.00613	CbGpPWpGaD
Valproic Acid—CYP2C18—Biological oxidations—ADH1B—pharynx cancer	0.00364	0.00611	CbGpPWpGaD
Valproic Acid—UGT1A9—Biological oxidations—CNDP2—pharynx cancer	0.00363	0.00609	CbGpPWpGaD
Valproic Acid—UGT2B7—Biological oxidations—ADH1B—pharynx cancer	0.00354	0.00594	CbGpPWpGaD
Valproic Acid—SLC22A5—saliva-secreting gland—pharynx cancer	0.00354	0.00874	CbGeAlD
Valproic Acid—ABAT—lymph node—pharynx cancer	0.0035	0.00866	CbGeAlD
Valproic Acid—CYP2B6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00337	0.00566	CbGpPWpGaD
Valproic Acid—SLC16A1—head—pharynx cancer	0.00335	0.00828	CbGeAlD
Valproic Acid—ACADSB—Metabolism—ADH7—pharynx cancer	0.0033	0.00554	CbGpPWpGaD
Valproic Acid—CYP3A5—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00329	0.00553	CbGpPWpGaD
Valproic Acid—UGT1A9—Biological oxidations—ADH7—pharynx cancer	0.00328	0.00551	CbGpPWpGaD
Valproic Acid—CYP2C8—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00325	0.00546	CbGpPWpGaD
Valproic Acid—UGT1A6—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00318	0.00534	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—CNDP2—pharynx cancer	0.0031	0.00521	CbGpPWpGaD
Valproic Acid—PTGS1—Biological oxidations—CNDP2—pharynx cancer	0.00296	0.00497	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling by NOTCH—CCND1—pharynx cancer	0.00295	0.00495	CbGpPWpGaD
Valproic Acid—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0029	0.00487	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—ADH1B—pharynx cancer	0.00289	0.00486	CbGpPWpGaD
Valproic Acid—CYP2A6—NRF2 pathway—ADH7—pharynx cancer	0.00288	0.00484	CbGpPWpGaD
Valproic Acid—UGT1A9—Biological oxidations—ADH1B—pharynx cancer	0.00288	0.00483	CbGpPWpGaD
Valproic Acid—CYP2C8—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00285	0.00479	CbGpPWpGaD
Valproic Acid—UGT1A9—PPAR Alpha Pathway—CCND1—pharynx cancer	0.00283	0.00476	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—ADH7—pharynx cancer	0.00281	0.00471	CbGpPWpGaD
Valproic Acid—CYP2A6—Biological oxidations—CNDP2—pharynx cancer	0.0028	0.0047	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—B4GALT5—pharynx cancer	0.00277	0.00465	CbGpPWpGaD
Valproic Acid—SLC22A5—trachea—pharynx cancer	0.00273	0.00674	CbGeAlD
Valproic Acid—PTGS1—Biological oxidations—ADH7—pharynx cancer	0.00267	0.00449	CbGpPWpGaD
Valproic Acid—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00265	0.00444	CbGpPWpGaD
Valproic Acid—HDAC2—lymph node—pharynx cancer	0.00264	0.00652	CbGeAlD
Valproic Acid—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00254	0.00427	CbGpPWpGaD
Valproic Acid—SLC22A8—head—pharynx cancer	0.00253	0.00626	CbGeAlD
Valproic Acid—CYP2A6—Biological oxidations—ADH7—pharynx cancer	0.00253	0.00425	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—ADH1B—pharynx cancer	0.00246	0.00413	CbGpPWpGaD
Valproic Acid—UGT1A4—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00245	0.00412	CbGpPWpGaD
Valproic Acid—PTGS1—epithelium—pharynx cancer	0.00242	0.00598	CbGeAlD
Valproic Acid—OGDH—Metabolism—B4GALT5—pharynx cancer	0.00235	0.00395	CbGpPWpGaD
Valproic Acid—SLC16A1—lymph node—pharynx cancer	0.00235	0.0058	CbGeAlD
Valproic Acid—PTGS1—Biological oxidations—ADH1B—pharynx cancer	0.00234	0.00394	CbGpPWpGaD
Valproic Acid—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00232	0.0039	CbGpPWpGaD
Valproic Acid—CYP1A2—Phase II conjugation—CNDP2—pharynx cancer	0.00227	0.00381	CbGpPWpGaD
Valproic Acid—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00226	0.0038	CbGpPWpGaD
Valproic Acid—CYP2B6—Biological oxidations—CNDP2—pharynx cancer	0.00226	0.00379	CbGpPWpGaD
Valproic Acid—CYP2A6—Biological oxidations—ADH1B—pharynx cancer	0.00222	0.00372	CbGpPWpGaD
Valproic Acid—SLC22A7—Fluoropyrimidine Activity—TP53—pharynx cancer	0.00222	0.00372	CbGpPWpGaD
Valproic Acid—CYP3A5—Biological oxidations—CNDP2—pharynx cancer	0.0022	0.0037	CbGpPWpGaD
Valproic Acid—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—pharynx cancer	0.0022	0.00369	CbGpPWpGaD
Valproic Acid—SLC22A5—spinal cord—pharynx cancer	0.00215	0.00532	CbGeAlD
Valproic Acid—PTGS1—trachea—pharynx cancer	0.00214	0.00529	CbGeAlD
Valproic Acid—CYP2B6—lymphoid tissue—pharynx cancer	0.00206	0.0051	CbGeAlD
Valproic Acid—CYP2B6—Biological oxidations—ADH7—pharynx cancer	0.00204	0.00343	CbGpPWpGaD
Valproic Acid—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00204	0.00343	CbGpPWpGaD
Valproic Acid—HDAC2—Notch Signaling Pathway—CCND1—pharynx cancer	0.00203	0.00342	CbGpPWpGaD
Valproic Acid—CYP3A5—Biological oxidations—ADH7—pharynx cancer	0.00199	0.00335	CbGpPWpGaD
Valproic Acid—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00198	0.00333	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling by NOTCH—TP53—pharynx cancer	0.00194	0.00326	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—CNDP2—pharynx cancer	0.00192	0.00322	CbGpPWpGaD
Valproic Acid—CYP2C8—Biological oxidations—CNDP2—pharynx cancer	0.00191	0.00321	CbGpPWpGaD
Valproic Acid—HDAC2—Regulation of Telomerase—CCND1—pharynx cancer	0.00186	0.00313	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—B4GALT5—pharynx cancer	0.00184	0.00309	CbGpPWpGaD
Valproic Acid—HDAC2—Neural Crest Differentiation—CDH1—pharynx cancer	0.00182	0.00306	CbGpPWpGaD
Valproic Acid—HDAC2—Cell Cycle—CDH1—pharynx cancer	0.00181	0.00304	CbGpPWpGaD
Valproic Acid—CYP2B6—Biological oxidations—ADH1B—pharynx cancer	0.00179	0.003	CbGpPWpGaD
Valproic Acid—CYP3A5—Biological oxidations—ADH1B—pharynx cancer	0.00175	0.00294	CbGpPWpGaD
Valproic Acid—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00174	0.00293	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—ADH7—pharynx cancer	0.00173	0.00291	CbGpPWpGaD
Valproic Acid—CYP2C8—Biological oxidations—ADH7—pharynx cancer	0.00173	0.0029	CbGpPWpGaD
Valproic Acid—CYP2C19—Biological oxidations—CNDP2—pharynx cancer	0.0017	0.00286	CbGpPWpGaD
Valproic Acid—PTGS1—spinal cord—pharynx cancer	0.00169	0.00418	CbGeAlD
Valproic Acid—UGT2B15—Metabolism—CNDP2—pharynx cancer	0.00168	0.00281	CbGpPWpGaD
Valproic Acid—CYP2B6—head—pharynx cancer	0.00166	0.00411	CbGeAlD
Valproic Acid—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—pharynx cancer	0.00164	0.00275	CbGpPWpGaD
Valproic Acid—CYP2C9—Biological oxidations—CNDP2—pharynx cancer	0.00155	0.00261	CbGpPWpGaD
Valproic Acid—CYP2C19—Biological oxidations—ADH7—pharynx cancer	0.00154	0.00259	CbGpPWpGaD
Valproic Acid—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00153	0.00257	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—ADH1B—pharynx cancer	0.00152	0.00255	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—ADH7—pharynx cancer	0.00152	0.00255	CbGpPWpGaD
Valproic Acid—CYP2C8—Biological oxidations—ADH1B—pharynx cancer	0.00151	0.00254	CbGpPWpGaD
Valproic Acid—PTGS1—head—pharynx cancer	0.0015	0.00371	CbGeAlD
Valproic Acid—HDAC2—Regulation of Telomerase—EGFR—pharynx cancer	0.00146	0.00246	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—B4GALT5—pharynx cancer	0.00145	0.00244	CbGpPWpGaD
Valproic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00141	0.00237	CbGpPWpGaD
Valproic Acid—CYP2C9—Biological oxidations—ADH7—pharynx cancer	0.00141	0.00236	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—CNDP2—pharynx cancer	0.0014	0.00235	CbGpPWpGaD
Valproic Acid—CYP2C19—Biological oxidations—ADH1B—pharynx cancer	0.00135	0.00227	CbGpPWpGaD
Valproic Acid—SLC22A5—lymph node—pharynx cancer	0.00134	0.00331	CbGeAlD
Valproic Acid—UGT2B15—Metabolism—ADH1B—pharynx cancer	0.00133	0.00223	CbGpPWpGaD
Valproic Acid—CYP1A2—Biological oxidations—CNDP2—pharynx cancer	0.00133	0.00223	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NOTCH—CCND1—pharynx cancer	0.00128	0.00215	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—B4GALT5—pharynx cancer	0.00127	0.00213	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—ADH7—pharynx cancer	0.00126	0.00212	CbGpPWpGaD
Valproic Acid—CYP2C9—Biological oxidations—ADH1B—pharynx cancer	0.00123	0.00207	CbGpPWpGaD
Valproic Acid—CYP1A2—Biological oxidations—ADH7—pharynx cancer	0.0012	0.00202	CbGpPWpGaD
Valproic Acid—CYP2A6—Fluoropyrimidine Activity—TP53—pharynx cancer	0.00119	0.002	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—ADH1B—pharynx cancer	0.00111	0.00186	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—CNDP2—pharynx cancer	0.00108	0.00181	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—B4GALT5—pharynx cancer	0.00106	0.00178	CbGpPWpGaD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—TP53—pharynx cancer	0.00106	0.00178	CbGpPWpGaD
Valproic Acid—CYP1A2—Biological oxidations—ADH1B—pharynx cancer	0.00105	0.00177	CbGpPWpGaD
Valproic Acid—PTGS1—lymph node—pharynx cancer	0.00105	0.0026	CbGeAlD
Valproic Acid—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	0.00102	0.00172	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—ADH7—pharynx cancer	0.000976	0.00164	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—CNDP2—pharynx cancer	0.000962	0.00162	CbGpPWpGaD
Valproic Acid—CYP3A4—Biological oxidations—ADH7—pharynx cancer	0.000927	0.00156	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—CNDP2—pharynx cancer	0.000898	0.00151	CbGpPWpGaD
Valproic Acid—HDAC2—Cell Cycle—TP53—pharynx cancer	0.000888	0.00149	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—ADH7—pharynx cancer	0.00087	0.00146	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—ADH1B—pharynx cancer	0.000856	0.00144	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NOTCH—TP53—pharynx cancer	0.000842	0.00141	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—EGFR—pharynx cancer	0.000821	0.00138	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—B4GALT5—pharynx cancer	0.000818	0.00137	CbGpPWpGaD
Valproic Acid—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.000813	0.00137	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—ADH7—pharynx cancer	0.000812	0.00136	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—B4GALT5—pharynx cancer	0.000797	0.00134	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—CNDP2—pharynx cancer	0.000785	0.00132	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—CNDP2—pharynx cancer	0.000763	0.00128	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—ADH1B—pharynx cancer	0.000763	0.00128	CbGpPWpGaD
Valproic Acid—HDAC2—Chromatin modifying enzymes—CCND1—pharynx cancer	0.000737	0.00124	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—B4GALT5—pharynx cancer	0.000729	0.00123	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—ADH1B—pharynx cancer	0.000712	0.0012	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—ADH7—pharynx cancer	0.000709	0.00119	CbGpPWpGaD
Valproic Acid—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—pharynx cancer	0.000705	0.00118	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—ADH7—pharynx cancer	0.00069	0.00116	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—TP53—pharynx cancer	0.000689	0.00116	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—B4GALT5—pharynx cancer	0.00068	0.00114	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—ADH1B—pharynx cancer	0.000622	0.00104	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CNDP2—pharynx cancer	0.00062	0.00104	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—ADH1B—pharynx cancer	0.000605	0.00102	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—B4GALT5—pharynx cancer	0.000595	0.000999	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—B4GALT5—pharynx cancer	0.000578	0.000971	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ADH7—pharynx cancer	0.000561	0.000942	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—TP53—pharynx cancer	0.000516	0.000867	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.000516	0.000867	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.000516	0.000867	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CNDP2—pharynx cancer	0.000506	0.000849	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ADH1B—pharynx cancer	0.000492	0.000826	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CNDP2—pharynx cancer	0.000478	0.000803	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—B4GALT5—pharynx cancer	0.00047	0.000789	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—EGFR—pharynx cancer	0.000464	0.000779	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ADH7—pharynx cancer	0.000457	0.000768	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ADH7—pharynx cancer	0.000432	0.000726	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ADH1B—pharynx cancer	0.000401	0.000673	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CNDP2—pharynx cancer	0.000386	0.000648	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—B4GALT5—pharynx cancer	0.000383	0.000644	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ADH1B—pharynx cancer	0.000379	0.000637	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CNDP2—pharynx cancer	0.000377	0.000633	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—B4GALT5—pharynx cancer	0.000362	0.000609	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ADH7—pharynx cancer	0.000349	0.000586	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ADH7—pharynx cancer	0.000341	0.000573	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—EGFR—pharynx cancer	0.000328	0.000551	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CNDP2—pharynx cancer	0.000327	0.000548	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ADH1B—pharynx cancer	0.000306	0.000514	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ADH1B—pharynx cancer	0.000299	0.000502	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ADH7—pharynx cancer	0.000295	0.000496	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CCND1—pharynx cancer	0.000293	0.000492	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—B4GALT5—pharynx cancer	0.000292	0.000491	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CNDP2—pharynx cancer	0.000291	0.00049	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—B4GALT5—pharynx cancer	0.000286	0.00048	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TP53—pharynx cancer	0.00027	0.000453	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CNDP2—pharynx cancer	0.000266	0.000446	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ADH7—pharynx cancer	0.000264	0.000443	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ADH1B—pharynx cancer	0.000259	0.000435	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—B4GALT5—pharynx cancer	0.000247	0.000416	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TP53—pharynx cancer	0.000247	0.000414	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ADH7—pharynx cancer	0.00024	0.000404	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ADH1B—pharynx cancer	0.000231	0.000388	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—EGFR—pharynx cancer	0.00023	0.000386	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CNDP2—pharynx cancer	0.000227	0.000381	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—B4GALT5—pharynx cancer	0.000221	0.000371	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ADH1B—pharynx cancer	0.000211	0.000354	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ADH7—pharynx cancer	0.000205	0.000345	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—B4GALT5—pharynx cancer	0.000201	0.000338	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TP53—pharynx cancer	0.000193	0.000324	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ADH1B—pharynx cancer	0.00018	0.000303	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.000175	0.000294	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—B4GALT5—pharynx cancer	0.000172	0.000289	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ADH7—pharynx cancer	0.000159	0.000266	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—EGFR—pharynx cancer	0.000142	0.000239	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ADH1B—pharynx cancer	0.000139	0.000233	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—B4GALT5—pharynx cancer	0.000133	0.000223	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCND1—pharynx cancer	0.000127	0.000213	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EGFR—pharynx cancer	9.96e-05	0.000167	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—pharynx cancer	8.36e-05	0.00014	CbGpPWpGaD
